Model-driven design of Mycoplasma as a vaccine chassis

Abstract

Chapter 1 Introduction Chapter 2 Model-driven design allows growth of Mycoplasma pneumoniae on serum-free media Chapter 3 Design of a fatty acid-prototrophic Mycoplasma pneumoniae strain through metabolic modelling Chapter 4 Galactocerebroside biosynthesis pathways of Mycoplasma species: an antigen triggering Guillain-Barré-Stohl syndrome Chapter 5 Mathematical models of biosafety circuits designed to limit Mycoplasma growth Chapter 6 Discussion